Clinical Trials on Advanced Solid Cancers in Belgium
Total 1908 results
-
Exscientia AI LimitedBiotrialTerminatedAdvanced Solid TumoursFrance, Belgium
-
MonTa Biosciences ApSAllucentRecruitingAdvanced Solid TumorBelgium, Denmark, Spain
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
PharmaMarRecruitingAdvanced Solid TumorBelgium, United States, Spain
-
Kling Biotherapeutics B.V.RecruitingAdvanced Solid Tumor MalignancyBelgium, Netherlands
-
Exscientia AI LimitedGT Apeiron LLCRecruitingAdvanced Solid TumorUnited Kingdom, Belgium
-
Xenothera SASRecruitingMetastatic Cancer | Advanced Solid TumorFrance, Belgium
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan
-
Pyxis Oncology, IncRecruiting
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
SOTIO Biotech AGRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Spain, Czechia, Belgium, France
-
University Hospital, GhentUniversity Ghent; Het LezerscollectiefCompletedAcute Leukemia | Advanced Solid TumorBelgium
-
AmgenCompletedAdvanced Solid TumorsUnited States, Belgium, Spain, Australia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedAdvanced Solid TumorsSpain, United States, Netherlands, Hungary, Italy, France, Belgium
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Belgium, Italy, Spain, Germany, Hong Kong, Hungary, Korea, Republic of, China, Czechia, Canada, United States, France, Poland, Thailand, Netherlands, Taiwan
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany
-
DeuterOncologyRecruitingAdult Solid Tumor | Lung Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Non-small Cell Carcinoma | Refractory Tumor | Hereditary Renal Papillary CancerFrance, Belgium, Netherlands
-
Hoffmann-La RocheCompletedAdvanced/Metastatic Solid TumorsUnited States, Belgium, Denmark, Spain, Netherlands, Canada, Italy
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
AZ-VUBAstraZeneca; Kom Op Tegen KankerRecruitingAdvanced Cancers Harbouring Mutations in HRGBelgium
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
iTeos Belgium SACompleted
-
OnxeoCompletedAdvanced CancerFrance, Belgium
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Jules Bordet InstituteUniversité Libre de Bruxelles; Fonds Gaston Ithier; Association Jules BordetRecruiting
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Korea, Republic of, Taiwan, China, Poland, Italy, Spain, Australia, Brazil, Argentina
-
Merus N.V.Incyte CorporationRecruitingAdvanced Cancer | Solid Tumor, Adult | B-cell Lymphoma, AdultUnited States, Spain, Belgium, Netherlands
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Hoffmann-La RocheCompletedSolid CancersUnited States, Belgium, France, Spain
-
Epizyme, Inc.Sponsor GmbHRecruitingHepatic Impairment | Advanced Malignant Solid TumorFrance, Belgium, United States, Poland, Slovakia
-
Incyte CorporationActive, not recruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsFrance, Spain, United States, China, United Kingdom, Lithuania, Germany, Ukraine, Finland, Italy, Belgium, Australia, Bulgaria, Latvia, New Zealand, Poland
-
Clovis Oncology, Inc.Bristol-Myers Squibb; European Network of Gynaecological Oncological Trial...SuspendedGynecologic Cancer | Advanced Solid TumorUnited States, Belgium, Spain, Germany, Austria, Italy
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Belgium, Canada
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedCancer | Solid TumorsFrance, Belgium, Australia, Netherlands
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Malignant Solid TumorsUnited States, Taiwan, United Kingdom, Hong Kong, Belgium, France, Spain, China, Netherlands, Poland, Sweden
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States, Belgium, Spain, France, United Kingdom, Canada, Denmark
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey